CPG
AXSM icon

Cornerstone Planning Group’s Axsome Therapeutics AXSM Stock Holding History

Cornerstone Planning Group’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.35K Buy
14
+9
+180% +$1.95K ﹤0.01% 1193
2026
Q1 		$1.12K Hold
5
– – ﹤0.01% 1434
2025
Q4 		$926 Hold
5
– – ﹤0.01% 1371
2025
Q3 		$666 Hold
5
– – ﹤0.01% 1418
2025
Q2 		$518 Hold
5
– – ﹤0.01% 1289
2025
Q1 		$521 Hold
5
– – ﹤0.01% 1289
2024
Q4 		$513 Buy
+5
New +$460 ﹤0.01% 1126

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Cornerstone Planning Group's AXSM Position: Q2 2026 in Review

Cornerstone Planning Group increased its Axsome Therapeutics (AXSM) stake by 180% in Q2 2026, buying an estimated $1.95K and bringing the position to 14 shares worth $3.35K. The position accounts for ﹤0.01% of the portfolio, ranked #1193.

Cornerstone Planning Group first reported a position in AXSM in Q4 2024 and has held it in 7 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Cornerstone Planning Group held 14 shares of Axsome Therapeutics worth $3.35K as of Q2 2026.
  • Cornerstone Planning Group bought 9 Axsome Therapeutics shares in Q2 2026, an estimated $1.95K.
  • Axsome Therapeutics made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #1193 holding.
  • Cornerstone Planning Group first reported a position in Axsome Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.